164 related articles for article (PubMed ID: 29907248)
1. Micro-RNA-181a suppresses progestin-promoted breast cancer cell growth.
Gu M; Wang L; Yang C; Li X; Jia C; Croteau S; Ruan X; Hardy P
Maturitas; 2018 Aug; 114():60-66. PubMed ID: 29907248
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-181a suppresses norethisterone-promoted tumorigenesis of breast epithelial MCF10A cells through the PGRMC1/EGFR-PI3K/Akt/mTOR signaling pathway.
Cai G; Wang Y; Houda T; Yang C; Wang L; Gu M; Mueck A; Croteau S; Ruan X; Hardy P
Transl Oncol; 2021 Jun; 14(6):101068. PubMed ID: 33730679
[TBL] [Abstract][Full Text] [Related]
3. Progestogens and membrane-initiated effects on the proliferation of human breast cancer cells.
Ruan X; Neubauer H; Yang Y; Schneck H; Schultz S; Fehm T; Cahill MA; Seeger H; Mueck AO
Climacteric; 2012 Oct; 15(5):467-72. PubMed ID: 22335423
[TBL] [Abstract][Full Text] [Related]
4. The presence of a membrane-bound progesterone receptor induces growth of breast cancer with norethisterone but not with progesterone: A xenograft model.
Zhao Y; Ruan X; Wang H; Li X; Gu M; Wang L; Li Y; Seeger H; Mueck AO
Maturitas; 2017 Aug; 102():26-33. PubMed ID: 28610679
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of progesterone receptor membrane component 1: possible mechanism for increased breast cancer risk with norethisterone in hormone therapy.
Neubauer H; Ruan X; Schneck H; Seeger H; Cahill MA; Liang Y; Mafuvadze B; Hyder SM; Fehm T; Mueck AO
Menopause; 2013 May; 20(5):504-10. PubMed ID: 23615641
[TBL] [Abstract][Full Text] [Related]
6. Membrane-initiated effects of progesterone on proliferation and activation of VEGF in breast cancer cells.
Neubauer H; Adam G; Seeger H; Mueck AO; Solomayer E; Wallwiener D; Cahill MA; Fehm T
Climacteric; 2009 Jun; 12(3):230-9. PubMed ID: 19340614
[TBL] [Abstract][Full Text] [Related]
7. Progestogens and PGRMC1-dependent breast cancer tumor growth: An in-vitro and xenograft study.
Ruan X; Gu M; Cai G; Zhao Y; Wang L; Li X; Mueck AO
Maturitas; 2019 May; 123():1-8. PubMed ID: 31027671
[TBL] [Abstract][Full Text] [Related]
8. Effects of estradiol and progestogens on human breast cells: regulation of sex steroid receptors.
Chen FP; Chien MH; Chen HY; Huang TS; Ng YT
Taiwan J Obstet Gynecol; 2013 Sep; 52(3):365-73. PubMed ID: 24075375
[TBL] [Abstract][Full Text] [Related]
9. Membrane-receptor initiated proliferative effects of dienogest in human breast cancer cells.
Schneck H; Ruan X; Seeger H; Cahill MA; Fehm T; Mueck AO; Neubauer H
Gynecol Endocrinol; 2013 Feb; 29(2):160-3. PubMed ID: 23116217
[TBL] [Abstract][Full Text] [Related]
10. Endometrial miR-181a and miR-98 expression is altered during transition from normal into cancerous state and target PGR, PGRMC1, CYP19A1, DDX3X, and TIMP3.
Panda H; Chuang TD; Luo X; Chegini N
J Clin Endocrinol Metab; 2012 Jul; 97(7):E1316-26. PubMed ID: 22492871
[TBL] [Abstract][Full Text] [Related]
11. The function role of miR-181a in chemosensitivity to adriamycin by targeting Bcl-2 in low-invasive breast cancer cells.
Zhu Y; Wu J; Li S; Ma R; Cao H; Ji M; Jing C; Tang J
Cell Physiol Biochem; 2013; 32(5):1225-37. PubMed ID: 24335172
[TBL] [Abstract][Full Text] [Related]
12. E2 + norethisterone promotes the PI3K-AKT pathway via PGRMC1 to induce breast cancer cell proliferation.
Zhang L; Ruan X; Gu M; Mueck AO
Climacteric; 2022 Oct; 25(5):467-475. PubMed ID: 35137666
[TBL] [Abstract][Full Text] [Related]
13. The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survival.
Menendez JA; Oza BP; Colomer R; Lupu R
Int J Oncol; 2005 Jun; 26(6):1507-15. PubMed ID: 15870863
[TBL] [Abstract][Full Text] [Related]
14. Medroxyprogesterone acetate-driven increase in breast cancer risk might be mediated via cross-talk with growth factors in the presence of progesterone receptor membrane component-1.
Zhou J; Yu Q; Chen R; Seeger H; Fehm T; Cahill MA; Mueck AO; Neubauer H
Maturitas; 2013 Oct; 76(2):129-33. PubMed ID: 23856385
[TBL] [Abstract][Full Text] [Related]
15. MiR-181a enhances drug sensitivity in mitoxantone-resistant breast cancer cells by targeting breast cancer resistance protein (BCRP/ABCG2).
Jiao X; Zhao L; Ma M; Bai X; He M; Yan Y; Wang Y; Chen Q; Zhao X; Zhou M; Cui Z; Zheng Z; Wang E; Wei M
Breast Cancer Res Treat; 2013 Jun; 139(3):717-30. PubMed ID: 23780685
[TBL] [Abstract][Full Text] [Related]
16. Progesterone receptor membrane component 1 is phosphorylated upon progestin treatment in breast cancer cells.
Willibald M; Bayer G; Stahlhut V; Poschmann G; Stühler K; Gierke B; Pawlak M; Seeger H; Mueck AO; Niederacher D; Fehm T; Neubauer H
Oncotarget; 2017 Sep; 8(42):72480-72493. PubMed ID: 29069804
[TBL] [Abstract][Full Text] [Related]
17. In vivo and in vitro effects of microRNA-27a on proliferation, migration and invasion of breast cancer cells through targeting of SFRP1 gene via Wnt/β-catenin signaling pathway.
Kong LY; Xue M; Zhang QC; Su CF
Oncotarget; 2017 Feb; 8(9):15507-15519. PubMed ID: 28099945
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of microRNA-181a may suppress proliferation and invasion and promote apoptosis of cervical cancer cells through the PTEN/Akt/FOXO1 pathway.
Xu H; Zhu J; Hu C; Song H; Li Y
J Physiol Biochem; 2016 Dec; 72(4):721-732. PubMed ID: 27534652
[TBL] [Abstract][Full Text] [Related]
19. Possible role of PGRMC1 in breast cancer development.
Neubauer H; Ma Q; Zhou J; Yu Q; Ruan X; Seeger H; Fehm T; Mueck AO
Climacteric; 2013 Oct; 16(5):509-13. PubMed ID: 23758160
[TBL] [Abstract][Full Text] [Related]
20. Progestin-mediated activation of MAPK and AKT in nuclear progesterone receptor negative breast epithelial cells: The role of membrane progesterone receptors.
Salazar M; Lerma-Ortiz A; Hooks GM; Ashley AK; Ashley RL
Gene; 2016 Oct; 591(1):6-13. PubMed ID: 27349565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]